Expression of LXR‑β, ABCA1 and ABCG1 in human triple‑negative breast cancer tissues
Previous studies have reported that liver X receptor (LXR), ATP‑binding cassette sub‑family G number 1 (ABCG1) and ATP‑binding cassette transporter number 1 (ABCA1), which are associated with cholesterol metabolism, may be associated with the development and progression of breast cancer. The expression levels of LXR‑β, ABCA1 and ABCG1 in triple‑negative breast cancer (TNBC) tissues and in non‑cancerous mammary tissues were observed by immunohistochemistry, quantum dot‑based immunohistochemistry, western blot analysis and reverse transcription‑quantitative polymerase chain reaction. The present study identified that the expression of ABCA1 in TNBC tissues was higher than that in non‑cancerous mammary tissues. A high expression of ABCA1 in the TNBC tissues was significantly associated with the histological grade. However, no significant differences were identified between the expression levels of LXR‑β and ABCG1 in the TNBC tissues compared with the non‑cancerous mammary tissues. Therefore, the findings of this study suggest that ABCA1 is a specific marker for TNBC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Oncology reports - 42(2019), 5 vom: 01. Nov., Seite 1869-1877 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pan, Hailing [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.02.2020 Date Revised 27.02.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3892/or.2019.7279 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300420846 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300420846 | ||
| 003 | DE-627 | ||
| 005 | 20231225102504.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3892/or.2019.7279 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1001.xml |
| 035 | |a (DE-627)NLM300420846 | ||
| 035 | |a (NLM)31432185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pan, Hailing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expression of LXR‑β, ABCA1 and ABCG1 in human triple‑negative breast cancer tissues |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.02.2020 | ||
| 500 | |a Date Revised 27.02.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Previous studies have reported that liver X receptor (LXR), ATP‑binding cassette sub‑family G number 1 (ABCG1) and ATP‑binding cassette transporter number 1 (ABCA1), which are associated with cholesterol metabolism, may be associated with the development and progression of breast cancer. The expression levels of LXR‑β, ABCA1 and ABCG1 in triple‑negative breast cancer (TNBC) tissues and in non‑cancerous mammary tissues were observed by immunohistochemistry, quantum dot‑based immunohistochemistry, western blot analysis and reverse transcription‑quantitative polymerase chain reaction. The present study identified that the expression of ABCA1 in TNBC tissues was higher than that in non‑cancerous mammary tissues. A high expression of ABCA1 in the TNBC tissues was significantly associated with the histological grade. However, no significant differences were identified between the expression levels of LXR‑β and ABCG1 in the TNBC tissues compared with the non‑cancerous mammary tissues. Therefore, the findings of this study suggest that ABCA1 is a specific marker for TNBC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a ABCA1 protein, human |2 NLM | |
| 650 | 7 | |a ABCG1 protein, human |2 NLM | |
| 650 | 7 | |a ATP Binding Cassette Transporter 1 |2 NLM | |
| 650 | 7 | |a ATP Binding Cassette Transporter, Subfamily G, Member 1 |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 650 | 7 | |a Liver X Receptors |2 NLM | |
| 650 | 7 | |a NR1H2 protein, human |2 NLM | |
| 700 | 1 | |a Zheng, Yue |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Qi |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Honglei |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Fuchun |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Di, Dingxin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncology reports |d 1994 |g 42(2019), 5 vom: 01. Nov., Seite 1869-1877 |w (DE-627)NLM09366334X |x 1791-2431 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2019 |g number:5 |g day:01 |g month:11 |g pages:1869-1877 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3892/or.2019.7279 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2019 |e 5 |b 01 |c 11 |h 1869-1877 | ||